Quarterly report pursuant to Section 13 or 15(d)

SEGMENT INFORMATION (Tables)

v3.8.0.1
SEGMENT INFORMATION (Tables)
3 Months Ended
Mar. 31, 2018
Segment Reporting [Abstract]  
Schedule of segment reporting information

Information with respect to these reportable business segments for the three months ended March 31, 2018 and 2017 was as follows:

  

    Three Months Ended
March 31, 2018
    Three Months Ended
March 31, 2017
 
Revenues            
Real property operating   $ 296,623     $    
Development services and sales of developed products     11,290          
Medical related consulting services – related party           66,286    
      307,913       66,286    
Depreciation and amortization                  
Real property operating     32,624          
Development services and sales of developed products     86,749          
Medical related consulting services – related party     4,006       26    
      123,379       26    
Interest expense                  
Real property operating     236,986          
Development services and sales of developed products              
Medical related consulting services – related party              
      236,986          
Net loss                  
Real property operating     (237,700 )        
Development services and sales of developed products     (173,474 )        
Medical related consulting services     (100,132 )     (549,333 )  
Other (a)     (1,039,663 )        
    $ (1,550,969 )   $ (549,333 )  

 

Identifiable long-lived tangible assets at March 31, 2018 and December 31, 2017   March 31, 2018     December 31, 2017  
Real property operating   $ 7,612,747     $ 7,645,371  
Development services and sales of developed products     120,396       5,857  
Medical related consulting services     17,224       20,558  
    $ 7,750,367     $ 7,671,786  

 

Identifiable long-lived tangible assets at March 31, 2018 and December 31, 2017   March 31, 2018     December 31, 2017  
United States   $ 7,613,567     $ 7,646,270  
China     136,800       25,516  
    $ 7,750,367     $ 7,671,786  

 

  (a) The Company does not allocate any general and administrative expense of its being a public company activities to its reportable segments as these activities are managed at a corporate level.